Redefining Medication Adherence in the Treatment of Schizophrenia: How Current Approaches to Adherence Lead to Misinformation and Threaten Therapeutic Relationships.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Psychiatric Clinics of North America

• Publication date

  2016-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psc.2016.01.004PMID 27216900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Real-world outcomes of paliperidone palmitate compared to daily oral antipsychotic therapy in schizophrenia: a randomized, open-label, review board-blinded 15-month study.

  2015cited by this paper
• Teaching clinical interviewing skills using role-playing: conveying empathy to performing a suicide assessment: a primer for individual role-playing and scripted group role-playing.

  2015cited by this paper
• The challenge of offering long-acting antipsychotic therapies: a preliminary discourse analysis of psychiatrist recommendations for injectable therapy to patients with schizophrenia.

  2015cited by this paper
• Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.

  2015cited by this paper
• Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.

  2014cited by this paper
• Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms.

  2014cited by this paper
• Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial.

  2013cited by this paper
• Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial

  2013cited by this paper
• A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia.

  2013cited by this paper
• Shared understanding in psychiatrist-patient communication: association with treatment adherence in schizophrenia.

  2013cited by this paper
• The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.

  2013cited by this paper
• The influence of therapeutic alliance and insight on medication adherence in schizophrenia

  2012cited by this paper
• When Psychopharmacology Is Not Enough: Using Cognitive Behavioral Therapy Techniques for Persons With Persistent Psychosis

  2012cited by this paper
• The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.

  2012cited by this paper
• [Individually-Tailored intervention promotes treatment adherence in psychotic patients: An RCT.] Op maat gesneden interventie bevordert therapietrouw bij psychotische patiënten: een RCT

  2011cited by this paper
• Long-acting injectable antipsychotics and the management of nonadherence

  2011cited by this paper
• Evidence-based pharmacotherapy of schizophrenia.

  2011cited by this paper
• Individually-tailored intervention promotes treatment adherence in psychotic patients: A randomized controlled trial (RCT)

  2011cited by this paper
• Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients.

  2011cited by this paper
• The Adherence Interview: Better Information, Better Alliance

  2011cited by this paper
• The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

  2010cited by this paper
• Measurement of psychiatric treatment adherence.

  2010cited by this paper
• Methodological challenges in psychiatric treatment adherence research.

  2010cited by this paper
• Treatment adherence therapy in people with psychotic disorders: randomised controlled trial.

  2010cited by this paper
• Strategies for Addressing Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations From the Expert Consensus Guidelines

  2010cited by this paper
• Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines

  2010cited by this paper
• Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness

  2009cited by this paper
• The “Medication Interest Model”: An Integrative Clinical Interviewing Approach for Improving Medication Adherence—Part 2 Implications for Teaching and Research

  2009cited by this paper
• Adherence to psychiatric treatments

  2009cited by this paper
• Medication compliance and persistence: terminology and definitions.

  2008cited by this paper
• Interventions for enhancing medication adherence.

  2008cited by this paper
• Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

  2008cited by this paper
• Interventions for enhancing medication adherence.

  2008cited by this paper
• Understanding and treating "first-episode" schizophrenia.

  2007cited by this paper
• Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

  2007cited by this paper
• Relationships among subjective and objective measures of adherence to oral antipsychotic medications.

  2007cited by this paper
• Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.

  2007cited by this paper
• Understanding and addressing adherence issues in schizophrenia: from theory to practice.

  2007cited by this paper
• Antipsychotic medication adherence in schizophrenia.

  2007cited by this paper
• Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

  2006cited by this paper
• Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study.

  2006cited by this paper
• Efficacy of the team solutions program for educating patients about illness management and treatment.

  2006cited by this paper
• Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.

  2006cited by this paper
• Use of environmental supports among patients with schizophrenia.

  2006cited by this paper
• A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.

  2005cited by this paper
• Defining and assessing adherence to oral antipsychotics: a review of the literature.

  2005cited by this paper
• Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.

  2004cited by this paper
• Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

  2004cited by this paper
• The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders.

  2003cited by this paper
• The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

  2003cited by this paper
• Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996.

  2002cited by this paper
• From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication.

  2002cited by this paper
• Predictors of noncompliance in patients with schizophrenia.

  2002cited by this paper
• Interventions to improve medication adherence in schizophrenia.

  2002cited by this paper
• The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion

  2002cited by this paper
• A systematic review of the associations between dose regimens and medication compliance.

  2001cited by this paper
• Update on family psychoeducation for schizophrenia.

  2000cited by this paper
• Determinants of medication compliance in schizophrenia: empirical and clinical findings.

  1997cited by this paper
• Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.

  1997cited by this paper
• Psychotherapeutic management techniques in the treatment of outpatients with schizophrenia.

  1994cited by this paper
• Maintenance medication for schizophrenia: strategies for dose reduction.

  1991cited by this paper
• Maintenance Medication for Schizophrenia: Strategies for Dose Reduction

  1991cited by this paper

• Psychopharmacotherapy of Schizophrenia with Long-Acting Antipsychotic Drugs in the Context of Expansion of Hospital-Substituting Forms of Psychiatric Care

  2025cites this paper
• Lies and LAIs: why accuracy of information is the key to understanding the benefits and the resistance to using long-acting formulation

  2025cites this paper
• A realist review of medication optimisation of community dwelling service users with serious mental illness

  2023cites this paper
• The role of pharmacists in supporting service users to optimise antipsychotic medication

  2023cites this paper
• Psychiatric rehabilitation patterns in Italy: Results from the Italian Society of Psychosocial Rehabilitation (SIRP) survey

  2023cites this paper
• Clinical and statistical analysis of factors affecting compliance in schizophrenia patients

  2023cites this paper
• Satisfaction with life as a compliance factor of patients with schizophrenia

  2023cites this paper
• Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

  2021cites this paper
• PPA_A_242693 1823..1842

  2020cites this paper
• Working with People with Mental Health Difficulties to Improve Adherence to Medication

  2020cites this paper
• Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics

  2020cites this paper
• Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics

  2020cites this paper
• Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: Psychometric properties of a new scale.

  2019cites this paper
• The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services

  2019cites this paper
• treatment adherence in schizophrenia: a literature review

  2018cites this paper
• Adesão à terapêutica nos doentes com esquizofrenia: uma revisão da literatura

  2018cites this paper
• The impact of self-stigmatization on medication attitude in schizophrenia patients.

  2018cites this paper
• Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?

  2017cites this paper